Brian Callaghan Selected Research

Brian Callaghan Research Topics

4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2013
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 11/2015
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2015 - 01/2014
1	Hypertension (High Blood Pressure) 01/2021
1	COVID-19 01/2021
1	Acute Coronary Syndrome 01/2021
1	Embolism (Embolus) 01/2021
1	Obesity 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Stroke (Strokes) 05/2020
1	Epilepsy (Aura) 10/2014
1	Pain (Aches) 01/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014
1	Neuralgia (Stump Neuralgia) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013
1	Muscular Diseases (Myopathy) 08/2013
1	Generalized Epilepsy 03/2011
1	Drug Resistant Epilepsy 03/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2011

3	NAD (NADH)IBA 01/2019 - 11/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 09/2013
1	SmokeIBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2020
1	Glucagon (Glukagon)FDA Link 11/2015
1	Exenatide (Byetta)FDA Link 11/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2015
1	Pharmaceutical PreparationsIBA 10/2014
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 08/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2011
1	SeleniumIBA 01/2011
1	MercuryIBA 01/2011
1	MetalsIBA 01/2011

1	Thrombectomy 05/2020
1	Percutaneous Coronary Intervention 05/2020
1	Therapeutics 01/2014
1	Glycemic Control 01/2014